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Surgical TechniquesHow to do it: Thoracoscopic left ventricular assist device
implantation using robot assistance
Zain Khalpey, MD, PhD, MRCS (Eng), Nicole Sydow, MD, Marvin J. Slepian, MD, and
Robert Poston, MD, Tucson, ArizLeft ventricular assist devices (LVADs) improve quality
of life and reduce mortality of patients with heart
failure.1 Although LVAD outcomes improve, unavoidable
consequences of implantation remain. Given the likeliness
of prior cardiac surgery, LVAD candidates for a ‘‘bridgeFIGURE 1. Placement of robotic port sites in intercostal spaces (ICS) and inci
ham, Mass) after implantation.
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The Journal of Thoracic and Carto transplant’’ raise concerns regarding the number of
redo sternotomies. Each sternotomy places patients at
greater risk for mortality, morbidity, and resource use (eg,
blood transfusions and length of stay).2 These increased
risks are attributed to patients’ heart failure associated
with sternum-adherent dilated right ventricles (RVs).3
Direct cardiac dissection of adhesions via sternotomy
can be poorly tolerated and trigger postoperative RV
failure by prolonged cardiopulmonary bypass (CPB) time,
bleeding, excessive transfusions, and inflammation. An
alternative to redo sternotomy is a robotic endoscopic
approach via thoracic chest ports. This indirect approach
to the retrosternal space improves adhesion visualization,
allowing more precise dissection. Reports of robotic use
for redo or high-risk cases led us to assess robotic utility
to reduce the invasiveness and morbidity in patients
undergoing LVAD implantation.sions with depiction of the HVAD (HeartWare International Inc, Framing-
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FIGURE 2. Total endoscopic anastomosis of outflow graft to aorta using the da Vinci robot (Intuitive Surgictal, Inc, Sunnyvale, Calif).
Surgical TechniquesCLINICAL SUMMARY
A 49-year-old man awaiting transplant with dilated
cardiomyopathy was evaluated for LVAD implantation
after a decompensated period of heart failure. A minia-
turized device (HVAD; HeartWare International Inc,
Framingham, Mass) was implanted into the left ventricular
apex via a left mini-thoracotomy incision. The da Vinci
robot (Intuitive Surgical, Inc, Sunnyvale, Calif) was used
to create the anastomosis of the outflow graft with the
ascending aorta. With the patient supine, the right femoral
vessels were cannulated for CPB. A small left anterior tho-
racotomy exposed the cardiac apex, localized via
preoperative chest computed tomography imaging, and
the inflow sewing ring was sutured into place. The pump
was positioned within the left thorax, and the drive line
was tunneled subcutaneously over the lower left ribs.
With the right lung isolated, 3 small robotic ports were
placed in the right chest via the second (left robotic arm),
third (camera and working port), and fifth (right robotic
arm) intercostal spaces in the anterior axillary line1424 The Journal of Thoracic and Cardiovascular Sur(Figure 1). Robotic assistance was used to pass the
outflow graft through a mediastinal tunnel created
anterior to the RV into the right chest for anastomosis
with the aorta (Figure 2). Direct visualization allowed for
accurate measurement and placement along the diaphragm
(conventional placement of outflow) and prevented kinking.
A side-biting clamp was placed onto the ascending aorta
via a stab incision in the first intercostal space, right of
midline with direct visualization to avoid injuring the right
internal thoracic artery. CPB was initiated after appropriate
activated clotting time–guided heparinization; an apical
core was removed from the left ventricle, and the HVAD
was secured into position. The outflow cannula was anasto-
mosed to the aorta with 5.0 running polytetrafluoroethylene
(Gore-Tex; WL Gore & Associates Inc, Flagstaff, Ariz) su-
ture performed initially by hand in the first few patients and
then totally endoscopically using robotic instruments with
and without a 2-cm right anterior thoracotomy. Once the de-
vice was placed, flow through the device was initiated, and
an angiocatheter was placed into the outflow graft to de-airgery c April 2014
Surgical Techniquesthrough the third intercostal space. The device was covered
with a polytetrafluoroethylene (Gore-Tex) mesh to mini-
mize lung adhesions.
For 7 cases, bypass times ranged from 68 to 136 minutes.
Intraoperative blood product use ranged from 0 to 3 units of
red blood cells, 2 to 3 units of fresh frozen plasma, and 1 to 2
pooled platelet units. Preoperatively, all patients had at least
moderate RV dysfunction determined by cardiac magnetic
resonance imaging (RV ejection fraction range, 20%-
35%). Yet, postoperative RV failure did not develop in
any of the patients. Four patients were extubated between
12 and 24 hours after surgery. The other 3 patients were ex-
tubated on postoperative days 2, 5, and 7.
DISCUSSION
As LVAD support for patients with heart failure becomes
increasingly popular, concern for redo sternotomies
increases.4 Further, reoperative sternotomy at the time of
subsequent heart transplantation has been associated with
decreased short- and long-term survival. To avoid redo
sternotomy, new methods of LVAD implantation must be
explored, particularly as new-generation devices become
smaller and more conducive to minimally invasive implan-
tation. Our approach improves on existing less-invasive
approaches for LVAD implantation because robotic
technology provides optimal visualization for RV
dissection and reduced risk of kinking the outflow graft.5
Performing the anastomosis of the graft to the ascending
aorta through right chest ports further decreases mediastinal
dissection. This may improve outcomes in these patients atFrom the Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston,
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The Journal of Thoracic and Carthe time of transplantation. Furthermore, the robotic ports
discussed are suitable for concomitant procedures usually
performed through the right chest.CONCLUSIONS
Refinements in surgical technique, teamdevelopment and
training methods, and patient selection and management
will enable robotic technology to play an important role
in LVAD implantation.
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